(Adds comments from credit-ratings firms, updates share price, in the fifth through seventh paragraphs.) By Jon Kamp Of DOW JONES NEWSWIRES Abbott Laboratories' (ABT) $6.6 billion purchase of Solvay SA's (SVYSY) drug business continues a busy stretch ...